| Aptamer/peptide‐functionalized genome‐editing system for effective immune restoration through reversal of PD‐L1‐mediated cancer immunosuppression XY He, XH Ren, Y Peng, JP Zhang, SL Ai, BY Liu, C Xu, SX Cheng Advanced materials 32 (17), 2000208, 2020 | 107 | 2020 |
| Aptamer-functionalized albumin-based nanoparticles for targeted drug delivery L Xu, XY He, BY Liu, C Xu, SL Ai, RX Zhuo, SX Cheng Colloids and Surfaces B: Biointerfaces 171, 24-30, 2018 | 63 | 2018 |
| A multi-functional macrophage and tumor targeting gene delivery system for the regulation of macrophage polarity and reversal of cancer immunoresistance XY He, BY Liu, C Xu, RX Zhuo, SX Cheng Nanoscale 10 (33), 15578-15587, 2018 | 56 | 2018 |
| A dual-targeting delivery system for effective genome editing and in situ detecting related protein expression in edited cells BY Liu, XY He, C Xu, L Xu, SL Ai, SX Cheng, RX Zhuo Biomacromolecules 19 (7), 2957-2968, 2018 | 55 | 2018 |
| A dual macrophage targeting nanovector for delivery of oligodeoxynucleotides to overcome cancer-associated immunosuppression XY He, BY Liu, JL Wu, SL Ai, RX Zhuo, SX Cheng ACS applied materials & interfaces 9 (49), 42566-42576, 2017 | 54 | 2017 |
| Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors BY Liu, XY He, RX Zhuo, SX Cheng Journal of controlled release 291, 90-98, 2018 | 38 | 2018 |
| Multi-drug loaded vitamin E-TPGS nanoparticles for synergistic drug delivery to overcome drug resistance in tumor treatment BY Liu, C Wu, XY He, RX Zhuo, SX Cheng Science bulletin 61 (7), 552-560, 2016 | 34 | 2016 |
| Multifunctional vector for delivery of genome editing plasmid targeting β-catenin to remodulate cancer cell properties XY He, BY Liu, Y Peng, RX Zhuo, SX Cheng ACS applied materials & interfaces 11 (1), 226-237, 2018 | 33 | 2018 |
| Co-delivery of multiple drug resistance inhibitors by polymer/inorganic hybrid nanoparticles to effectively reverse cancer drug resistance C Wu, MQ Gong, BY Liu, RX Zhuo, SX Cheng Colloids and Surfaces B: Biointerfaces 149, 250-259, 2017 | 33 | 2017 |
| Facile strategy to enhance specificity and sensitivity of molecular beacons by an aptamer-functionalized delivery vector C Xu, XY He, Y Peng, BS Dai, BY Liu, SX Cheng Analytical chemistry 92 (2), 2088-2096, 2019 | 31 | 2019 |
| Functional polymer/inorganic hybrid nanoparticles for macrophage targeting delivery of oligodeoxynucleotides in cancer immunotherapy XY He, BY Liu, SL Ai, L Xu, RX Zhuo, SX Cheng Materials Today Chemistry 4, 106-116, 2017 | 29 | 2017 |
| Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector BY Liu, XY He, RX Zhuo, SX Cheng Nanoscale 10 (45), 21209-21218, 2018 | 21 | 2018 |
| Peptide and aptamer decorated delivery system for targeting delivery of Cas9/sgRNA plasmid to mediate antitumor genome editing BY Liu, XY He, C Xu, XH Ren, RX Zhuo, SX Cheng ACS applied materials & interfaces 11 (27), 23870-23879, 2019 | 19 | 2019 |
| Targeting delivery of oligodeoxynucleotides to macrophages by mannosylated cationic albumin for immune stimulation in cancer treatment SL Ai, XY He, BY Liu, RX Zhuo, SX Cheng Molecular pharmaceutics 16 (6), 2616-2625, 2019 | 18 | 2019 |
| Development of a double shmiR lentivirus effectively targeting both BCL11A and ZNF410 for enhanced induction of fetal hemoglobin to treat β-hemoglobinopathies B Liu, C Brendel, DS Vinjamur, Y Zhou, C Harris, M McGuinness, ... Molecular Therapy 30 (8), 2693-2708, 2022 | 16 | 2022 |
| Fusion peptide functionalized hybrid nanoparticles for synergistic drug delivery to reverse cancer drug resistance JL Wu, XY He, BY Liu, MQ Gong, RX Zhuo, SX Cheng Journal of materials chemistry B 5 (24), 4697-4704, 2017 | 15 | 2017 |
| Self-Assembled Plasmid Delivery System for PPM1D Knockout to Reverse Tumor Malignancy XH Ren, XY He, BY Liu, C Xu, SX Cheng ACS Applied Bio Materials 3 (11), 7831-7839, 2020 | 3 | 2020 |
| Highly Efficient One-Step Tagging of Endogenous Genes in Primary Cells Using CRISPR-Cas Ribonucleoproteins Y Yao, J Cao, W Wang, B Liu, X Pei, L Zhang, S Rao The CRISPR Journal 5 (6), 843–853, 2022 | 1 | 2022 |
| Treating Sickle Cell Disease with Lentiviral Vectors Combining an Anti-Sickling beta (AS3)-Globin Gene with BCL11A and ZNF410 MicroRNA Adapted Short Hairpin RNAs KL Hart, B Liu, RP Hollis, C Brendel, DA Williams, DB Kohn MOLECULAR THERAPY 30 (4), 60-60, 2022 | 1 | 2022 |
| A novel high-titer, bifunctional lentiviral vector for autologous hematopoietic stem cell gene therapy of sickle cell disease KL Hart, B Liu, D Brown, B Campo-Fernandez, K Tam, K Orr, RP Hollis, ... Molecular Therapy Methods & Clinical Development 32 (2), 2024 | | 2024 |
